We hypothesised that altered activation of CHK1 by ATR in response to MYC-induced DNA replication stress in Eμ-Myc/cRel−/− lymphoma cells could affect CHK1 inhibitor sensitivity. This evidence concerns the gene CHEK1 and lymphoma.